Biotech investors sound alarm on Senate drug-pricing bill

  • 📰 WashTimes
  • ⏱ Reading Time:
  • 1 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 4%
  • Publisher: 63%

Health Health Headlines News

Health Health Latest News,Health Health Headlines

A group of biotech investors and doctors are warning that the Senate’s drug-pricing proposal, aimed at lowering skyrocketing prices, would “strike a huge blow” to patient access and halt research on new treatments for Alzheimer’s disease, heart disease and cancer.

 

Thank you for your comment. Your comment will be published after being reviewed.
Please try again later.

“We can’t price gouge on a small set of drugs?!?!” “We won’t innovate if we don’t see hand over fist increasing profits ever year!”

We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

 /  🏆 235. in HEALTH

Health Health Latest News, Health Health Headlines